Disc Medicine, Inc. (IRON)
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Disc Medicine, Inc.
NASDAQ:IRONHealthcare · Biotechnology
-0.69%$74.51
AH Close$74.83+0.43%vs close
AH Close$74.83+0.43%vs close
Mkt Cap$3.31B
Float32.73M
O/S44.39M
Inst Own98.0%
SI22.2%
Dilution
MCap$3.31B
Float32.73M
O/S44.39M
Dilution